查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1474934

IV 敷料市场规模、份额和趋势分析报告：按类型、最终用途、地区、细分市场预测，2024-2030 年

IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, Translucent), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

静脉注射敷料市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球静脉输液敷料市场规模预计将达到 12.1 亿美元。

预计 2024 年至 2030 年复合年增长率为 5.50%。 CLABSI 和 CRBSI 等血源性感染的增加以及住院患者人数的增加预计将提振市场需求。此外，老年人口的增加和慢性病盛行率的增加也是推动市场成长的因素。例如，根据世界卫生组织称，2015年至2050年间，老年人口比例预计将翻一番，从12%增至22%，使老年成为慢性病的重要危险因子。提高静脉疗法在治疗包括癌症在内的各种慢性疾病方面的认识和采用，预计将推动市场成长。多家公司正在推出新的静脉注射疗法。

例如，2023 年 1 月，Glenmark Pharmaceuticals Ltd. 在印度推出了 AKYNZEO IV，一种静脉感染剂，用于预防化疗引起的呕吐和噁心。主要企业的策略性倡议（例如收购）预计将有助于市场成长。例如，2022年9月，B. Braun Medical Inc.从Starboard Medical收购了导管固定产品。这项措施预计将改善患者照护并扩大公司的静脉注射治疗产品，包括静脉注射敷料。此外，主要企业的地理扩张活动预计将促进市场成长。例如，2022 年 1 月，Smith + Nephew 开设了一个新的商业地点，以扩大其在北欧地区的产品供应。

静脉注射敷料市场报告亮点

  • 透明产品细分市场在2023年占据最大市场占有率，预计2024年至2030年将以5.71%的最快复合年增长率成长。
  • 这是由于引入了一种新型透明膜敷料，其凝胶贴片浸有洛赫西定酸氯己定，可在导管使用期间对部位进行持续消毒。
  • 由于医疗保健投资高、住院人数不断增加以及感染疾病和慢性病的发病率，医院最终用途细分市场在 2023 年占据最大收入份额，为 45.39%。
  • 2023年，北美地区的销售份额最大，为45.46%。这是由于发达的医疗基础设施、大量的老年人口以及对静脉治疗的认识和采用不断提高。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章第四章敷料市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • IV 敷料市场分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 IV 服装：类型估计/趋势分析

  • 静脉输液敷料市场：类型变化分析
    • 透明的
    • 半透明

第五章 IV 选矿：最终用途估算与趋势分析

  • 静脉注射敷料市场：最终用途变化分析

第六章第四章 敷料市场：区域估算与趋势分析

  • 全球区域市场概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 3M
    • RICHARDSON HEALTHCARE, INC.
    • MEDLINE INDUSTRIES
    • SMITH &NEPHEW
    • CARDINAL HEALTH
    • CONVATEC GROUP PLC
    • PAUL HARTMANN AG
    • LOHMANN &RAUSCHER（L&R）
    • MCKESSON CORPORATION
    • MOLNLYCKE HEALTH CARE AB
    • DERMARITE INDUSTRIES, LLC
    • DEROYAL INDUSTRIES, INC.
    • BSN MEDICAL
    • DYNAREX CORPORATION.
    • KOMAL HEALTH CARE PVT. LTD.
    • SENTRY MEDICAL
    • SHANDONG DERMCOSY MEDICAL CO.,LTD.
Product Code: GVR-4-68040-247-2

IV Dressing Market Growth & Trends:

The global IV dressing market size is anticipated to reach USD 1.21 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.50% from 2024 to 2030. Increasing cases of blood infections, such as CLABSI and CRBSI, and a rising number of hospital admissions are likely to boost market demand. Also, the rising geriatric population and increasing prevalence of chronic disorders are factors contributing to market growth. For instance, according to the WHO, between 2015 and 2050, the proportion of geriatric population is expected to double from 12% to 22%, making old age a significant risk factor for developing chronic disorders. A rise in awareness and adoption of IV therapy for treating various chronic diseases including cancer is anticipated to drive market growth. Various players are launching novel IV therapies.

For instance, in January 2023, Glenmark Pharmaceuticals Ltd. launched the IV infection formulation AKYNZEO IV in India to prevent chemotherapy-induced vomiting and nausea. Strategic initiatives undertaken by top players, such as acquisitions, are expected to contribute to market growth. For instance, in September 2022, B. Braun Medical Inc. acquired catheter securement products from Starboard Medical. This initiative was anticipated to improve patient care and extend the company's IV therapy offering including IV dressing. Furthermore, geographical expansion activities by key players are projected to boost market growth. For instance, in January 2022, Smith+Nephew inaugurated a new commercial hub to increase the company's product offerings in the Nordic region.

IV Dressing Market Report Highlights:

  • The transparent product segment accounted for the largest market share in 2023 and is expected to grow at the fastest CAGR of 5.71% from 2024 to 2030
  • This is owing to the introduction of a novel transparent film dressing with a chlorhexidine gluconate-impregnated gelpatch to offer ongoing disinfection of the site throughout the duration of the catheter
  • The hospitals end-use segment held the largest revenue share of 45.39% in 2023 owing to the high healthcare investments, a rise in the number of hospitalizations, and incidences of infectious & chronic diseases
  • North America captured the largest revenue share of 45.46% in 2023. This is owing to the well-developed healthcare infrastructure, high geriatric population, and rise in the awareness & adoption of IV therapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
      • 1.6.1.3. Volume price analysis (Model 2)
      • 1.6.1.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. I.V. Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing cases of blood infections such as CLABSI and CRBSI
      • 3.2.1.2. Increasing hospital admission
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Complications associated with I.V. dressing
  • 3.3. I.V. Dressing Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. I.V. Dressing: Type Estimates & Trend Analysis

  • 4.1. I.V. Dressing Market: Type Movement Analysis
    • 4.1.1. Transparent
      • 4.1.1.1. Transparent market estimates and forecast, 2018 - 2030
    • 4.1.2. Translucent
      • 4.1.2.1. Translucent market estimates and forecast, 2018 - 2030

Chapter 5. I.V. Dressing: End-use Estimates & Trend Analysis

  • 5.1. I.V. Dressing Market: End-use Movement Analysis
    • 5.1.1. Hospitals
      • 5.1.1.1. Hospitals market estimates and forecast 2018 to 2030, (USD million)
    • 5.1.2. Clinics
      • 5.1.2.1. Clinics Institutes market estimates and forecast 2018 to 2030, (USD Million)
    • 5.1.3. Others
      • 5.1.3.1. Others market estimates and forecast 2018 to 2030, (USD million)

Chapter 6. I.V. Dressing Market: Regional Estimates & Trend Analysis

  • 6.1. Global Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. China
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. 3M
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. RICHARDSON HEALTHCARE, INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MEDLINE INDUSTRIES
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. SMITH & NEPHEW
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. CARDINAL HEALTH
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. CONVATEC GROUP PLC
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. PAUL HARTMANN AG
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LOHMANN & RAUSCHER (L&R)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. MCKESSON CORPORATION
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. MOLNLYCKE HEALTH CARE AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. DERMARITE INDUSTRIES, LLC
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. DEROYAL INDUSTRIES, INC.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. BSN MEDICAL
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. DYNAREX CORPORATION.
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. KOMAL HEALTH CARE PVT. LTD.
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. SENTRY MEDICAL
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. SHANDONG DERMCOSY MEDICAL CO.,LTD.
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global I.V. Dressing Market, By Region 2018 - 2030 (USD Million)
  • Table 4. Global I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 5. Global I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 8. North America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 12. Canada I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Europe I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 14. Europe I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 15. Europe I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. UK I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 17. UK I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. Germany I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 19. Germany I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. France I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. France I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Italy I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Italy I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. Spain I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Spain I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Denmark I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 27. Denmark I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Sweden I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. Sweden I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Norway I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Norway I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Japan I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 36. Japan I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. China I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. China I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. India I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. India I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Australia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 42. Australia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. Thailand I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Thailand I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. South Korea I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. South Korea I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Latin America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Latin America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Latin America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50. Brazil I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 51. Brazil I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Mexico I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 53. Mexico I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 55. Argentina I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. MEA I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. MEA I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. MEA I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. South Africa I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. UAE I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 I.V. Dressing market: Market snapshot
  • Fig. 9 I.V. Dressing market: Market segmentation
  • Fig. 10 I.V. Dressing market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 I.V. Dressing market driver impact
  • Fig. 16 I.V. Dressing market restraint impact
  • Fig. 17 I.V. Dressing market porter's five forces analysis
  • Fig. 18 I.V. Dressing market PESTEL analysis
  • Fig. 19 I.V. Dressing market: Type movement Analysis
  • Fig. 20 I.V dressing market: type outlook and key takeaways
  • Fig. 21 Transparent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Translucent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 I.V. dressing market: End use movement Analysis
  • Fig. 24 I.V. dressing market: End use outlook and key takeaways
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global I.V. Dressing market: Regional movement analysis
  • Fig. 29 Global I.V. Dressing market: Regional outlook and key takeaways
  • Fig. 30 Global market share, by region
  • Fig. 31 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)